Polar Capital Holdings PLC Legend Biotech Corp Transaction History
Polar Capital Holdings PLC
- $16.3 Billion
- Q3 2024
A detailed history of Polar Capital Holdings PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Polar Capital Holdings PLC holds 496,238 shares of LEGN stock, worth $17.9 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
496,238
Previous 206,632
140.16%
Holding current value
$17.9 Million
Previous $9.15 Million
164.24%
% of portfolio
0.15%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding LEGN
# of Institutions
228Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$402 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$270 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$239 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$206 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$181 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.03B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...